Cargando…
A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
N-butyl cyanoacrylate, one of embolic materials, is usually used as a mixture with Lipiodol (N-butyl cyanoacrylate–Lipiodol mixture). N-butyl cyanoacrylate–Lipiodol–Iopamidol was developed by adding a nonionic iodine contrast agent (Iopamiron) to N-butyl cyanoacrylate–Lipiodol mixture. N-butyl cyano...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172629/ https://www.ncbi.nlm.nih.gov/pubmed/37179814 http://dx.doi.org/10.1016/j.radcr.2023.04.005 |
_version_ | 1785039649006157824 |
---|---|
author | Fukamatsu, Fumiaki Sugiura, Kazusa Takekoshi, Daiya Fukuzawa, Takuya Oyama, Kazuki Tsukahara, Yoshinori Kurozumi, Masahiro Shimizu, Akira Fujinaga, Yasunari |
author_facet | Fukamatsu, Fumiaki Sugiura, Kazusa Takekoshi, Daiya Fukuzawa, Takuya Oyama, Kazuki Tsukahara, Yoshinori Kurozumi, Masahiro Shimizu, Akira Fujinaga, Yasunari |
author_sort | Fukamatsu, Fumiaki |
collection | PubMed |
description | N-butyl cyanoacrylate, one of embolic materials, is usually used as a mixture with Lipiodol (N-butyl cyanoacrylate–Lipiodol mixture). N-butyl cyanoacrylate–Lipiodol–Iopamidol was developed by adding a nonionic iodine contrast agent (Iopamiron) to N-butyl cyanoacrylate–Lipiodol mixture. N-butyl cyanoacrylate–Lipiodol–Iopamidol has lower adhesiveness than N-butyl cyanoacrylate–Lipiodol mixture and the ability to form a single large droplet. We report the case of a 63-year-old man with a ruptured splenic artery aneurysm treated by transcatheter arterial embolization using N-butyl cyanoacrylate–Lipiodol–Iopamidol. He was referred to the emergency room because of sudden onset of upper abdominal pain. A diagnosis was established using contrast-enhanced computed tomography and angiography. Emergency transcatheter arterial embolization was performed, and the ruptured splenic artery aneurysm was successfully embolized using a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamidol packing. This case demonstrates the usefulness of a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamdol packing for the embolization of aneurysms. |
format | Online Article Text |
id | pubmed-10172629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101726292023-05-12 A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol Fukamatsu, Fumiaki Sugiura, Kazusa Takekoshi, Daiya Fukuzawa, Takuya Oyama, Kazuki Tsukahara, Yoshinori Kurozumi, Masahiro Shimizu, Akira Fujinaga, Yasunari Radiol Case Rep Case Report N-butyl cyanoacrylate, one of embolic materials, is usually used as a mixture with Lipiodol (N-butyl cyanoacrylate–Lipiodol mixture). N-butyl cyanoacrylate–Lipiodol–Iopamidol was developed by adding a nonionic iodine contrast agent (Iopamiron) to N-butyl cyanoacrylate–Lipiodol mixture. N-butyl cyanoacrylate–Lipiodol–Iopamidol has lower adhesiveness than N-butyl cyanoacrylate–Lipiodol mixture and the ability to form a single large droplet. We report the case of a 63-year-old man with a ruptured splenic artery aneurysm treated by transcatheter arterial embolization using N-butyl cyanoacrylate–Lipiodol–Iopamidol. He was referred to the emergency room because of sudden onset of upper abdominal pain. A diagnosis was established using contrast-enhanced computed tomography and angiography. Emergency transcatheter arterial embolization was performed, and the ruptured splenic artery aneurysm was successfully embolized using a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamidol packing. This case demonstrates the usefulness of a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamdol packing for the embolization of aneurysms. Elsevier 2023-04-29 /pmc/articles/PMC10172629/ /pubmed/37179814 http://dx.doi.org/10.1016/j.radcr.2023.04.005 Text en © 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Fukamatsu, Fumiaki Sugiura, Kazusa Takekoshi, Daiya Fukuzawa, Takuya Oyama, Kazuki Tsukahara, Yoshinori Kurozumi, Masahiro Shimizu, Akira Fujinaga, Yasunari A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol |
title | A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol |
title_full | A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol |
title_fullStr | A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol |
title_full_unstemmed | A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol |
title_short | A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol |
title_sort | ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–lipiodol–iopamidol |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172629/ https://www.ncbi.nlm.nih.gov/pubmed/37179814 http://dx.doi.org/10.1016/j.radcr.2023.04.005 |
work_keys_str_mv | AT fukamatsufumiaki arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT sugiurakazusa arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT takekoshidaiya arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT fukuzawatakuya arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT oyamakazuki arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT tsukaharayoshinori arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT kurozumimasahiro arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT shimizuakira arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT fujinagayasunari arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT fukamatsufumiaki rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT sugiurakazusa rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT takekoshidaiya rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT fukuzawatakuya rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT oyamakazuki rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT tsukaharayoshinori rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT kurozumimasahiro rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT shimizuakira rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol AT fujinagayasunari rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol |